Cost analysis of febrile neutropenia (FN) management in three tumour types in Germany

20651 Background: FN is the most frequent dose-limiting toxicity of myelosuppressive chemotherapy (CT). To date there are few data on the costs of FN management in Germany. Methods: Prospective, mu...